EMBs (Eye Movement Biomarkers) is the acronym coined by Innodem Neurosciences and refers to a quantitative assessment of eye movements. Some of these quantitative measures include saccades, anti-saccades, pursuit, velocity, latency and amplitude.
GMBs (Gaze Mapping Biomarkers) quantitatively measure various aspects of human cognition by analyzing gaze patterns produced while individuals perform short visual tasks. GMBs can help to measure, for instance, attention, and aid in disease tracking.
Our patented software technology determines gaze positions of eyes and is useful in various applications. It is capable of working with almost any off-the-shelf camera that is found on most smartphones and tablets today.